On-chip micro-flow polystyrene bead-based immunoassay for quantitative detection of tacrolimus (FK506).

Tacrolimus (FK506) is a widely used immunosuppressant for preventing allograft rejection and the treatment of atopic dermatitis. FK506 necessitates therapeutic drug monitoring because of inter- and intrapatient variability and the lack of correlation between the administered dose and the blood concentration. Previous immunoassay-based methods required a relatively long assay time and troublesome liquid-handling procedures. In the present study, we aimed to establish a rapid monitoring method for FK506 determination by using a poly(dimethylsiloxane) (PDMS)-based microfluidic device. Polystyrene beads were coated with mouse anti-FK506 antibody and placed in the flow channel. As a competitive assay, sample solution was allowed to react in the flow channel. After the addition of the fluorogenic substrate, the fluorescent signal was observed under a microscope. As a result, the developed assay allowed a short detection time of approximately 15 min per each sample and a high sensitivity even by using only a single bead. The feasibility of performing a competitive assay using a PDMS-based antibody chip gives promising results over the existing immunoassay-based methods.

[1]  C. Staatz,et al.  Comparison of an ELISA and an LC/MS/MS Method for Measuring Tacrolimus Concentrations and Making Dosage Decisions in Transplant Recipients , 2002, Therapeutic drug monitoring.

[2]  P. Kandela South Africa: medical care of detainees. , 1985, Lancet.

[3]  M. Christiaans,et al.  Dosing and management guidelines for tacrolimus in renal transplant patients. , 1999, Transplantation proceedings.

[4]  H. Schiebel,et al.  Simplified High‐Performance Liquid Chromatography‐Mass Spectrometry Assay for Measurement of Tacrolimus and Its Metabolites and Cross‐Validation with Microparticle Enzyme Immunoassay , 1995, Therapeutic drug monitoring.

[5]  D. Faulds,et al.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. , 1993, Drugs.

[6]  F. Berthoux,et al.  Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  G. Klintmalm FK 506: an update. , 1994, Clinical transplantation.

[8]  T. Starzl,et al.  FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION , 1989, The Lancet.

[9]  P. Wallemacq,et al.  HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients. , 1995, Clinical chemistry.

[10]  A. Alak,et al.  An HPLC/MS/MS assay for tacrolimus in patient blood samples. Correlation with results of an ELISA assay. , 1997, Journal of pharmaceutical and biomedical analysis.

[11]  T. Starzl,et al.  A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. , 1991, Transplantation proceedings.

[12]  P. Taylor,et al.  Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. , 1998, Clinical chemistry.

[13]  N. Undre,et al.  Pharmacokinetics of tacrolimus: clinically relevant aspects. , 1999, Transplantation proceedings.

[14]  P. Wong,et al.  A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents. , 1996, Therapeutic drug monitoring.

[15]  S. Nishimura,et al.  Pharmacokinetic animal PET study of FK506 as a potent neuroprotective agent. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  W. Jusko Analysis of Tacrolimus (FK 506) in Relation to Therapeutic Drug Monitoring , 1995, Therapeutic drug monitoring.

[17]  Mangan Kf Immunologic control of hemopoiesis: implications for quality of the graft after allogeneic bone marrow transplantation. , 1987 .

[18]  D. Stephen,et al.  Evaluation of the Dade Behring Syva® EMIT 2000 tacrolimus assay on the Bayer Advia 1650 , 2003, Annals of clinical biochemistry.

[19]  M. Kobayashi,et al.  A whole blood FK 506 assay for the IMx analyzer. , 1991, Transplantation proceedings.